Towards early detection and disease interception of COPD across the lifespan.

Eur Respir Rev

Respiratory Institute, Hospital Clinic, University of Barcelona, FCRB-IDIBAPS, CIBER Enfermedades Respiratorias, Barcelona, Spain.

Published: July 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

COPD is "a heterogeneous lung condition characterized by chronic respiratory symptoms due to abnormalities of the airways and/or alveoli that cause persistent, often progressive, airflow obstruction". COPD has been traditionally associated with tobacco smoking and accelerated lung function decline. However, our understanding of the pathogenesis of COPD has changed significantly over the past few years due to the recognition that different lung function trajectories starting in early life and progressing across the lifespan are also important pathways to COPD. Further, today, it is well accepted that there are multiple genetic, host and environmental factors (, aetiotypes) that can cause COPD and contribute to its clinical heterogeneity. Here, we review current understanding of the environmental, genomic and immune factors associated with the early-life origins of COPD. We also discuss the current knowledge gaps and how this new knowledge can facilitate earlier detection and disease interception of COPD across the lifespan, thus reducing its disease burden and improving the well-being and prognosis of COPD patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12238877PMC
http://dx.doi.org/10.1183/16000617.0243-2024DOI Listing

Publication Analysis

Top Keywords

copd
9
detection disease
8
disease interception
8
interception copd
8
copd lifespan
8
lung function
8
early detection
4
lifespan copd
4
copd heterogeneous
4
heterogeneous lung
4

Similar Publications

Purpose: Sleep disturbance is prevalent in long-term care facilities (LTCFs), yet there is limited understanding of individual factors predicting changes in sleep within these populations. Our objective was to determine predictors of sleep disturbance in LTCFs and investigate variation in prevalence across facilities in two Canadian provinces-New Brunswick and Saskatchewan.

Method: This retrospective longitudinal cohort study used interRAI comprehensive health assessment data from 2016 to 2021, encompassing 21,394 older adults aged ≥ 65 years across 228 LTCFs.

View Article and Find Full Text PDF

Immunotherapies for Aging and Age-Related Diseases: Advances, Pitfalls, and Prospects.

Research (Wash D C)

September 2025

NHC Key Laboratory of Tropical Disease Control, School of Life Sciences and Medical Technology, Hainan Medical University, Haikou, Hainan 571199, China.

Aging is characterized by a gradual decline in the functionality of all the organs and tissues, leading to various diseases. As the global population ages, the urgency to develop effective anti-aging strategies becomes increasingly critical due to the growing severity of associated health problems. Immunotherapy offers novel and promising approaches to combat aging by utilizing approaches including vaccines, antibodies, and cytokines to target specific aging-related molecules and pathways.

View Article and Find Full Text PDF

Chronic Obstructive Pulmonary Disease (COPD) is a prevalent chronic respiratory disorder characterized by airway inflammation and irreversible airflow limitation. Its marked heterogeneity and complexity pose significant challenges to traditional clinical assessments in terms of prognostic prediction and personalized management. In recent years, the exploration of biomarkers has opened new avenues for the precise evaluation of COPD, particularly through multi-biomarker prediction models and integrative multimodal data strategies, which have substantially improved the accuracy and reliability of prognostic assessments.

View Article and Find Full Text PDF

Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of death worldwide, with abdominal fat, particularly visceral fat, closely associated with its onset and progression. While the lipid accumulation product (LAP) has been linked to COPD risk, it is not sufficient to fully reflect the level of visceral fat. In contrast, the body roundness index (BRI), a more accurate measure of abdominal fat distribution, has not been fully explored in relation to COPD.

View Article and Find Full Text PDF